BMA book awards - an annual Medical Book Competition, established in 1996, which aims to encourage and reward excellence in medical publishing. Judging takes place in three stages and all entries are individually appraised by specialists and educators.

2006: 'Post-traumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care'. [Highly commended] [link to guideline]

Lancet paper of the year award:

CJ Whittington, T Kendall, P Fonagy, D Cottrell, A Cotgrove and E Boddington. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004; 363: 1341–1345. [PubMed - indexed for Medline]

R Horton. Read all about it: The Lancet's Paper of the Year, Lancet 2003; 362: 2101–2103. [PubMed - indexed for Medline]

Other commendations for our work:

Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS. Schizophrenia practice 1. guidelines: international survey and comparison. Br J Psychiatry 2005; 187: 248–55. [PubMed - indexed for Medline]

BMA patient information awards - part of the BMA medical book competition, this award was established in 1997 to recognise quality in written patient information leaflets and small booklets.

Patient Information Award for 'Mental Health Problems During Pregnancy and After Giving Birth'. 2008. [Commended]

Patient Information Award for 'Treatments for Drug Misuse'. 2008. [Commended]

Patient Information Award for 'Treating Obsessive-Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD) in adults, children and young people'. 2006. [Commended]

Patient Information Award for 'Self-Harm: Short-Term Treatment and Management'. 2005. [Highly commended]

Patient Information Award for 'Eating Disorders: Anorexia Nervosa, Bulimia Nervosa and Related Eating Disorders'. 2004. [Highly commended].

Patient Information Award for 'Treating and Managing Schizophrenia (Core Interventions)'. 2003. [Commended]

Alcohol dependence and harfmul alcohol use, published February 2011:

This guideline, one of the three clinical guidelines in the NICE series on alcohol-use disorders, provides an excellent review of current thinking on the assessment, treatment and management of harmful drinking and alcohol dependence. It is at once readable, practical, comprehensive and evidence-based, constituting one of the best formulas for delivering effective care and treatment that I have seen... Thomas F Babor, PhD, MPH, Professor and chairman, Department of community medicine and health Care, University of Connecticut school of Medicine.

Anxiety (partial update), published Janurary 2011:

This guideline contains a much needed update on the treatment of generalised anxiety disorder. Recent evidence - especially in the area of health economic modelling of pharmacological interventions - is expertly considered. A vital resource that will help all healthcare professionals to understand this prevalent but often under recognised disorders and provide the most effective treatment... David M Chark FBA, FMedSci, FBPsS, FKC, Professor of Psychology, IOP.

Schizophrenia, published September 2010:

The original nice schizophrenia guideline was of remarkable superiority in its methodological quality compared with other national treatment guidelines t throughout the world. This updated version of the guideline is yet again of exceptional quality, demonstrating rigour in its development, clarity in its presentation and noticeable breadth in its coverage. Whether dealing with drug and psychosocial treatments, patient experience, ethnic minorities or health economics, based on current evidence the guideline opens up new vistas on the best treatments available for people with schizophrenia. A landmark of schizophrenia practice guidelines... Professor Wolfgang Gaebel, MD, Professor of Psychiatry, Director, Department of Psychiatry and psychotherapy of the Heinrich-Heine-University, Dusseldorf and past President German Psychiatric association (DGPPN ).

There are still many inequalities that exist in mental health, some of which are particularly pertinent for people with schizophrenia, such as not getting access to effective and evidence based psychological and pharmacological treatments. These inequalities are even more difficult to overcome for people from ethnic minorities, who often gain access to help at a very late stage. This guideline is the first to tackle these problematic issues fy undertaking a full evidence review of the problems faced by people from African Caribbean groups in accessing UK services. The guideline provides all the evidence underpinning which services and treatments work for people with schizophrenia, including people from black and minority ethnic groups, such as family interventions, CBTT, arts therapies and careful use of antipsychotics. I can thoroughly recommend this world class guideline to anyone with an interest in the evidence about what works for people with schizophrenia... Professor Dinesh Bhugra MA, MSc, MBBS, FRCPsych, MPhil, PhD, President, Royal College of Psychiatrists.

Depression update, published October 2009:

This guideline is an authoritative, comprehensive and up-to-date review of the evidence-based treatment of depression. It provides clear guidance on the effective treatment of depression and will be of real value to all clinicians and patients... Steven D. Hollon, Professor of Psychology, Vanderbilt University, Nashville, Tennessee.

Attention Deficit Hyperactivity Disorder (ADHD), published September 2008:

This book provides a comprehensive and discerning reference that will be of interest to students, clinicians and researchers, not only for its clinical practice guidelines, but also for its thorough review of the history, epidemiology and aetiology of ADHD. The guideline development group has tackled thorny issues in a systematic, evidenced-based manner. Readers will find sound answers to the many questions about ADHD that arise in research and practice: Does it remit in adulthood? Is it caused by genes or environment? How should it be diagnosed and treated throughout the lifespan? What impairments afflict patients and families? And what are the costs to society? Although this book was developed to provide a national clinical practice guideline for the UK, that description does not do justice to the breadth and depth of the work. It is most certainly relevant to students and researchers and to clinicians around the world who will likely keep it close at hand as a definitive guide to ADHD... Stephen V. Faraone, Professor of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University.

These NICE practice guidelines provide clear, authoritative advice on the diagnosis and management of ADHD. It is most helpful that there should be such a strong, evidence-based document available to guide practitioners in this controversial field. It should be essential reading for all commissioners, managers, primary care and specialist clinicians who are involved with children with this diagnosis... Philip Graham, Emeritus Professor of Child Psychiatry, Institute of Child Health, University of London.

Antenatal and Postnatal Mental Health (APMH), published February 2007:

One in seven women will have some kind of psychological problem during the antenatal and postnatal periods and it is absolutely vital that healthcare professionals, including midwives and health visitors, are able to identify those women who are at risk of developing a mental health problem during pregnancy and giving birth. This guideline is an indispensable tool to aid professionals in that endeavour... Dr Gwyneth Lewis, National Clinical Lead for Maternal Health and Maternity Services and Director of the Maternal Deaths Enquiry for CEMACH.

Dementia, published November 2006:

The NICE-SCIE guideline is a brilliant synthesis of evidence about constitutes effective care for people with dementia and their families. I would strongly encourage all commissioners, provider managers and clinicians involved in caring for people with dementia to read the guideline and develop services in line with it... Professor Ian Philips, National Director for Older People's Services and Neurological Conditions and Professor of Health Care for Older People, University of Sheffield.

This outstanding and comprehensive work really does deal with the full depth of evidence available about the treatment of dementia. I thoroughly recommend this to clinicians, health and social care practitioners and academics with an interest in this field. It is an invaluable resource for anyone who wants to look at what the evidence says... Professor Louis Appleby CBE, National Director for Mental Health, Professor of Psychiatry, University of Manchester.